Life sciences companies have challenging business models. The silver lining is that this pandemic has shone a light on the importance of medical and health innovation. Read more on the push toward additional government funding and a friendlier regulatory environment for life sciences companies.
See the full story here:
https://www.torys.com/insights/publications/2020/05/pandemics-mandate-to-innovate-a-turning-point-for-life-sciences